Similar articles for PMID: 11781246

Year	Number of Results
1990	2
1992	2
1993	1
1994	2
1995	4
1996	10
1997	2
1998	2
1999	9
2000	10
2001	19
2002	22
2003	11
2004	5
2005	9
2006	5
2007	6
2008	11
2009	14
2010	19
2011	19
2012	19
2013	25
2014	15
2015	3
2016	4
2017	2
2018	9
2019	10
2020	19
2021	27
2022	23
2023	9
2024	0

1

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW. Skinnider BF, et al. Blood. 2002 Jan 15;99(2):618-26. doi: 10.1182/blood.v99.2.618. Blood. 2002. PMID: 11781246 Free article.

2

The role of interleukin 13 in classical Hodgkin lymphoma.

Skinnider BF, Kapp U, Mak TW. Skinnider BF, et al. Leuk Lymphoma. 2002 Jun;43(6):1203-10. doi: 10.1080/10428190290026259. Leuk Lymphoma. 2002. PMID: 12152987 Review.

3

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Trümper LH, von Bonin F, Kapp U, Patterson B, Snow BE, Mak TW. Skinnider BF, et al. Blood. 2001 Jan 1;97(1):250-5. doi: 10.1182/blood.v97.1.250. Blood. 2001. PMID: 11133768 Free article.

4

Interleukin 13: a growth factor in hodgkin lymphoma.

Skinnider BF, Kapp U, Mak TW. Skinnider BF, et al. Int Arch Allergy Immunol. 2001 Dec;126(4):267-76. doi: 10.1159/000049523. Int Arch Allergy Immunol. 2001. PMID: 11815733 Review.

5

Lymphomagenesis in Hodgkin lymphoma.

Matsuki E, Younes A. Matsuki E, et al. Semin Cancer Biol. 2015 Oct;34:14-21. doi: 10.1016/j.semcancer.2015.02.002. Epub 2015 Feb 25. Semin Cancer Biol. 2015. PMID: 25725205 Review.

6

Molecular biology of Hodgkin lymphoma.

Küppers R. Küppers R. Hematology Am Soc Hematol Educ Program. 2009:491-6. doi: 10.1182/asheducation-2009.1.491. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008234 Review.

7

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.

Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, Dörken B, Zenke M, Stein H, Scheidereit C. Hinz M, et al. J Exp Med. 2002 Sep 2;196(5):605-17. doi: 10.1084/jem.20020062. J Exp Med. 2002. PMID: 12208876 Free PMC article.

8

Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.

Natoli A, Lüpertz R, Merz C, Müller WW, Köhler R, Krammer PH, Li-Weber M. Natoli A, et al. Int J Cancer. 2013 Oct 15;133(8):1945-54. doi: 10.1002/ijc.28189. Epub 2013 Apr 25. Int J Cancer. 2013. PMID: 23553437 Free article.

9

Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.

Oshima Y, Puri RK. Oshima Y, et al. Cell Immunol. 2001 Jul 10;211(1):37-42. doi: 10.1006/cimm.2001.1828. Cell Immunol. 2001. PMID: 11585386

10

Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.

Stanelle J, Döring C, Hansmann ML, Küppers R. Stanelle J, et al. Blood. 2010 Nov 18;116(20):4202-11. doi: 10.1182/blood-2010-01-265827. Epub 2010 Jul 26. Blood. 2010. PMID: 20660789 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

315 results

Results by year